🇺🇸 FDA
Pipeline program

Recombinant subunit B/bacterial cholera vaccine (enteric-coated capsules)

OCV-YJFA-2024-001

Approved mab active

Quick answer

Recombinant subunit B/bacterial cholera vaccine (enteric-coated capsules) for Diarrhea is a Approved program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Diarrhea
Phase
Approved
Modality
mab
Status
active

Clinical trials